OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Preventive Cardiology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of th	355
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study	338
Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017	253
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19)	223
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice	202
The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiolo	120
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European A	105
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases	93
Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the Euro	86
Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic	82
Effectiveness of home-based cardiac telerehabilitation as an alternative to Phase 2 cardiac rehabilitation of coronary heart disease: a systematic review and meta-analysis	71
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular	71
HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies	71
Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on H	70
Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: A nationwide population-based cohort study	66
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–2019	65
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead	64
Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction	63
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation	57
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings	56
Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis	54
Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the	51
Role of gender, age and BMI in prognosis of heart failure	47
Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies	46
Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis	45

Sport and exercise during and beyond the COVID-19 pandemic	45
Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic	42
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing	40
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working	40
Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys	40
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions	39
Physical exercise training in patients with a Fontan circulation: A systematic review	38
Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis	37
Obesity, overweight and risk for cardiovascular disease and mortality in young women	37
Future-proofing cardiac rehabilitation: Transitioning services to telehealth during COVID-19	37
Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990−2019: findings from 2019 global burden of disease study	37
Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation	36
Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations	36
Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project	36
Effects of exercise rehabilitation in patients with long coronavirus disease 2019	36